Respuesta: Biomarcadores inflamatorios en el síndrome coronario agudo

Galán, Amparo; Curós, Antonio.
Med. clín (Ed. impr.) ; 136(10): 462-462, abr. 2011.
Artículo en Español | IBECS (España) | ID: ibc-89081

Documentos relacionados

  1. Diagnostic Accuracy of Ischemia-Modified Albumin for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
  2. Pseudo precordial ST-segment depression.
  3. [Value of glycosylated hemoglobin A1c and apolipoprotein A-1 ratio on predicting outcome of patients with acute coronary syndrome].
  4. From Suspicion to Recognition-Being a Bystander to a Relative Affected by Acute Coronary Syndrome.
  5. Brain Natriuretic Peptide for Predicting Contrast-Induced Acute Kidney Injury in Patients with Acute Coronary Syndrome Undergoing Coronary Angiography: A Systematic Review and Meta-Analysis.
  6. Acute Coronary Syndrome: Diagnostic Evaluation.
  7. Ceramides and pro-inflammatory cytokines for the prediction of acute coronary syndrome: a multi-marker approach.
  8. One fits all hs troponin or more personalized dual markers strategies in the primary diagnostic assessment of patients with suspected acute coronary syndrome?
  9. Performance of a Novel Research-Use-Only Secretoneurin ELISA in Patients with Suspected Acute Coronary Syndrome: Comparison with an Established Secretoneurin Radioimmunoassay.
  10. To rule-in, or not to falsely rule-out, that is the question: evaluation of hs-cTnT EQA performance in light of the ESC-2020 guideline.